Comment: Laparoscopic versus open resection for colorectal liver metastases

CheckMate-142: Updated data from MSI high metastatic colon cancer patients

BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-mutated/HR /HER2- advanced breast cancer

Advances in PARP inhibitor use for metastatic breast cancer

Margetuximab for the treatment of HER2-positive breast cancer

The future of PARP inhibitors in metastatic breast cancer

DORA: Using olaparib alone or with durvalumab in platinum responsive advanced triple-negative breast cancer

EMBRACA: Results of talazoparib vs chemotherapy relative to prior CT in patients with advanced breast cancer

ECHO palliative care in Africa: Improving access to quality palliative care

Developments in neoadjuvant immunotherapy options for early-stage lung cancer patients

Implementing the Breast Health Global Initiative guidelines

A phase II study of bemcentinib with pembrolizumab in patients with advanced NSCLC